Your browser doesn't support javascript.
loading
The impact of omalizumab on paid and unpaid work productivity among severe Japanese cedar pollinosis (JCP) patients.
Müller, M; Igarashi, A; Hashiguchi, K; Kappel, M; Paolini, F; Yoshisue, H; Funakubo, M; Sharma, H; Okano, M.
Afiliação
  • Müller M; Unit of Health Economics, WifOR Institute, Darmstadt, Hesse, Germany.
  • Igarashi A; Unit of Public Health and Preventive Medicine, Yokohama City University School of Medicine, Yokohama, Japan.
  • Hashiguchi K; Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.
  • Kappel M; Unit of Otorhinolaryngology, Futaba Clinic, Tokyo, Japan.
  • Paolini F; Unit of Health Economics, WifOR Institute, Darmstadt, Hesse, Germany.
  • Yoshisue H; Unit of Health Economics, WifOR Institute, Darmstadt, Hesse, Germany.
  • Funakubo M; Unit of Health Economics, Novartis Pharma K.K, Tokyo, Japan.
  • Sharma H; Unit of Health Economics, Novartis Pharma K.K, Tokyo, Japan.
  • Okano M; Novartis Corporation Sdn. Bhd, Selangor, Malaysia.
J Med Econ ; 25(1): 220-229, 2022.
Article em En | MEDLINE | ID: mdl-35072591

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Rinite Alérgica Sazonal / Cryptomeria Limite: Humans Idioma: En Revista: J Med Econ Assunto da revista: SERVICOS DE SAUDE Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Rinite Alérgica Sazonal / Cryptomeria Limite: Humans Idioma: En Revista: J Med Econ Assunto da revista: SERVICOS DE SAUDE Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha